checkAd
    Startseite > Aktien > IN8bio > Nachrichten
    IN8bio Aktie
    1,1200
     
    EUR
    +16,67 %
    +0,1600 EUR
    Letzter Kurs 31.05.24 Tradegate
    1,0700
     
    EUR
    3.760 STK
    Geldkurs 31.05.24
    1,1600
     
    EUR
    3.426 STK
    Briefkurs 31.05.24
    ISIN: US45674E1091 · WKN: A2QF49 · SYM: 6JH · USA

    Neueste Nachrichten

    IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
    24.05.24 · globenewswire · IN8bio
    IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
    23.05.24 · globenewswire · IN8bio
    IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
    14.05.24 · globenewswire · IN8bio
    IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024
    13.05.24 · globenewswire · IN8bio
    IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
    09.05.24 · globenewswire · IN8bio
    IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
    30.04.24 · globenewswire · IN8bio
    IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
    24.04.24 · globenewswire · IN8bio
    IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
    16.04.24 · globenewswire · IN8bio
    IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
    09.04.24 · globenewswire · IN8bio
    IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
    14.03.24 · globenewswire · IN8bio
    IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024
    05.03.24 · globenewswire · IN8bio
    IN8bio to Present at Upcoming Investor Conferences
    26.02.24 · Business Wire (engl.) · IN8bio